Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Knockdown of MCM10 Gene Impairs Glioblastoma Cell Proliferation, Migration and Invasion and the Implications for the Regulation of Tumorigenesis


Minichromosome maintenance 10 (MCM10) plays an important role in DNA replication and is expressed in a variety of tumors, including glioma. However, its role and mechanism in glioma remain elusive. The purpose of this study was to examine the molecular function of MCM10 in glioblastoma cell lines in vitro and to further investigate the molecular mechanisms in the network mediated by MCM10. Cell proliferation, invasion, and migration were investigated in the absence of MCM10 mediated by RNA interference (RNAi) in U87 and U251 cell lines. Microarray data were obtained from U87 cells infected with a lentivirus expressing a small interfering RNA (siRNA) targeting MCM10, and ingenuity pathway analysis (IPA) was performed. Molecular signaling pathways, gene functions, and upstream and downstream regulatory genes and networks were analyzed. MCM10 was positively stained in human glioblastoma multiforme (GBM) samples according to immunohistochemistry. Silencing MCM10 in U87 and U251 cells significantly reduced cell proliferation, migration, and invasion. In U87 cells transfected with MCM10, 274 genes were significantly upregulated, while 313 genes were downregulated. IPA revealed that MCM10 is involved in the IGF-1 signaling pathway, and calcitriol appears to be a significant upstream regulator of MCM10. Other factors, such as TWIST1 and Stat3, also interact within the MCM10-mediated network. Our data indicate that MCM10 is involved in the regulation of GBM in vitro and may provide more evidence for understanding the molecular mechanisms of this fatal disease.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6


  1. Baxley RM, Bielinsky AK (2017) Mcm10: a dynamic scaffold at eukaryotic replication forks. Genes 8.

  2. Beer TM, Myrthue A (2004) Calcitriol in cancer treatment: from the lab to the clinic. Mol Cancer Ther 3:373–381

  3. Bielinsky AK (2016) Mcm10: the glue at replication forks. Cell Cycle 15:3024–3025.

  4. Calvano SE et al (2005) A network-based analysis of systemic inflammation in humans. Nature 437:1032–1037.

  5. Cui F, Hu J, Ning S, Tan J, Tang H (2018) Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer. Prostate 78:1299–1310.

  6. Das M, Prasad SB, Yadav SS, Govardhan HB, Pandey LK, Singh S, Pradhan S, Narayan G (2013) Over expression of minichromosome maintenance genes is clinically correlated to cervical carcinogenesis. PloS One 8:e69607.

  7. Erkan EP et al (2014) Depletion of minichromosome maintenance protein 7 inhibits glioblastoma multiforme tumor growth in vivo. Oncogene 33:4778–4785.

  8. Felciano RM, Bavari S, Richards DR, Billaud JN, Warren T, Panchal R, Kramer A (2013) Predictive systems biology approach to broad-spectrum, host-directed drug target discovery in infectious diseases Pacific Symposium on Biocomputing Pacific Symposium on Biocomputing:17–28

  9. Homesley L, Lei M, Kawasaki Y, Sawyer S, Christensen T, Tye BK (2000) Mcm10 and the MCM2-7 complex interact to initiate DNA synthesis and to release replication factors from origins. Genes Dev 14:913–926

  10. Hua C, Zhao G, Li Y, Bie L (2014) Minichromosome maintenance (MCM) family as potential diagnostic and prognostic tumor markers for human gliomas. BMC Cancer 14:526.

  11. Ishimi Y (2018) Regulation of MCM2-7 function. Genes Genet Syst 93:125–133.

  12. Izumi M et al (2017) The Mcm2-7-interacting domain of human mini-chromosome maintenance 10 (Mcm10) protein is important for stable chromatin association and origin firing. J Biol Chem 292:13008–13021.

  13. Kang Y, Massague J (2004) Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118:277–279.

  14. Koppen A et al (2007) Direct regulation of the minichromosome maintenance complex by MYCN in neuroblastoma. Eur J Cancer 43:2413–2422.

  15. Li WM et al (2016) MCM10 overexpression implicates adverse prognosis in urothelial carcinoma. Oncotarget 7:77777–77792.

  16. Lim HJ, Jeon Y, Jeon CH, Kim JH, Lee H (2011) Targeted disruption of Mcm10 causes defective embryonic cell proliferation and early embryo lethality. Biochim Biophys Acta 1813:1777–1783.

  17. Magrassi L, Butti G, Pezzotta S, Infuso L, Milanesi G (1995) Effects of vitamin D and retinoic acid on human glioblastoma cell lines. Acta Neurochir 133:184–190.

  18. Mahadevappa R et al (2018) DNA replication licensing protein MCM10 promotes tumor progression and is a novel prognostic biomarker and potential therapeutic target in breast cancer. Cancers:10.

  19. Mikheev AM et al (2018) Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma. Mol Oncol 12:1188–1202.

  20. Omuro A, De Angelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310:1842–1850.

  21. Padmanabhan V, Callas P, Philips G, Trainer TD, Beatty BG (2004) DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer. J Clin Pathol 57:1057–1062.

  22. Polo SE, Almouzni G (2005) Histone metabolic pathways and chromatin assembly factors as proliferation markers. Cancer Lett 220:1–9.

  23. Ramnath N et al (2001) MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer. J Clin Oncol 19:4259–4266.

  24. Reubens MC, Biller MD, Bedsole SE, Hopkins LT, Ables ET, Christensen TW (2015) Mcm10 is required for oogenesis and early embryogenesis in Drosophila. Mech Dev 138 Pt 3:291–299.

  25. Rousseau A, Mokhtari K, Duyckaerts C (2008) The 2007 WHO classification of tumors of the central nervous system - what has changed? Curr Opin Neurol 21:720–727.

  26. Salomon DG et al (2014) Vitamin D receptor expression is associated with improved overall survival in human glioblastoma multiforme. J Neurooncol 118:49–60.

  27. Schuldiner O, Benvenisty N (2001) A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors. Oncogene 20:4984–4994.

  28. Sclafani RA, Holzen TM (2007) Cell cycle regulation of DNA replication. Annu Rev Genet 41:237–280.

  29. Scott IS, Morris LS, Rushbrook SM, Bird K, Vowler SL, Burnet NG, Coleman N (2005) Immunohistochemical estimation of cell cycle entry and phase distribution in astrocytomas: applications in diagnostic neuropathology. Neuropathol Appl Neurobiol 31:455–466.

  30. Senfter D et al (2017) Overexpression of minichromosome maintenance protein 10 in medulloblastoma and its clinical implications. Pediatri Blood Cancer 64.

  31. Soling A, Sackewitz M, Volkmar M, Schaarschmidt D, Jacob R, Holzhausen HJ, Rainov NG (2005) Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma. Clin Cancer Res 11:249–258

  32. Stillman B (2005) Origin recognition and the chromosome cycle. FEBS Lett 579:877–884.

  33. Wharton SB, Chan KK, Anderson JR, Stoeber K, Williams GH (2001) Replicative Mcm2 protein as a novel proliferation marker in oligodendrogliomas and its relationship to Ki67 labelling index, histological grade and prognosis. Neuropathol Appl Neurobiol 27:305–313

  34. Yang WD, Wang L (2019) MCM10 facilitates the invaded/migrated potentials of breast cancer cells via Wnt/beta-catenin signaling and is positively interlinked with poor prognosis in breast carcinoma. J Biochem Mol Toxicol 33:e22330.

  35. Yoshida K, Inoue I (2004) Regulation of Geminin and Cdt1 expression by E2F transcription factors. Oncogene 23:3802–3812.

Download references


This work was supported by Beijing Natural Science Foundation (7172041). Peng Kang is supported by Beijing Municipal Administration of Hospitals ‘Youth Program’ (QMS20180512) and Beijing Program of Excellent Young Investigator (2015000021469G221).

Author information

All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Peng Kang, Zhe Han, and Heng Zhang. The first draft of the manuscript was written by Peng Kang and Yongji Tian, and all the authors commented on previous versions of the manuscript. All the authors read and approved the final manuscript.

Correspondence to Wang Jia or Yongji Tian.

Ethics declarations

Ethical Statement

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material


(XLSX 45 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kang, P., Han, Z., Liao, Z. et al. Knockdown of MCM10 Gene Impairs Glioblastoma Cell Proliferation, Migration and Invasion and the Implications for the Regulation of Tumorigenesis. J Mol Neurosci (2020).

Download citation


  • MCM10
  • Glioma
  • Proliferation
  • Migration
  • IPA